Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Monday, July 6, 2026
🇺🇸 FDA

Kresladi News

🇺🇸 FDA ← All news

FDA Kresladi coverage for business development, investment, and market access teams

High impact NewsApr 11, 2026

FDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I Marks Medical Breakthrough

FDA · Rare genetic immunodeficiency disorders · 3 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.